Susheel Umesh
-
Biocon Biologics expands footprint in emerging markets
Takes over the commercialization of biosimilars susiness from Viatris in 70+ countries Biocon Biologics has completed the integration of the acquired…
Read More » -
Biocon Biologics appoints Susheel Umesh as CCO for emerging markets
Umesh has over 30 years of experience in the pharmaceuticals industry Biocon Biologics, a unit of biotechnology major Biocon, has…
Read More »